June 5, 2023 – TOMI, a global company specializing in disinfection and decontamination solutions, announced that it has entered into a contract with Vizient, increasing TOMI’s presence in the U.S. healthcare system.
Vizient serves approximately 97% of the nation’s Academic Medical Centers, more than 50% of the nation’s acute care health system and serves more than 20% of the nation’s ambulatory market. This contract enables TOMI to supply SteraMist systems to a wide range of healthcare providers, including academic medical centers, pediatric facilities, and community health providers, through Vizient’s nationwide network.
TOMI underwent a rigorous competitive procurement process and was selected as an approved supplier in the category of Automated Room Disinfection for SteraMist systems that will begin October 1, 2023. The company’s dedication to providing Vizient with comprehensive documentation and validation of SteraMist iHP technology played a crucial role in securing this opportunity.
Through the Vizient contract, TOMI aims to enhance infection prevention and control measures across the healthcare industry. By making SteraMist systems readily accessible to a wide range of healthcare providers, TOMI seeks to contribute to the creation of safer and healthier environments for patients, staff, and visitors alike. With SteraMist’s cutting-edge technology and proven efficacy, TOMI is poised to make a positive impact on healthcare facilities’ ability to maintain disinfected spaces, ultimately improving patient outcomes and overall safety.